A clinical and neurophysiological investigation of whether levodopa treatment is associated with peripheral polyneuropathy in people with Parkinson’s disease.

If levodopa contributes to neuropathy via metabolic changes (e.g., B12/homocysteine pathways), the finding could guide monitoring, simple supplementation or management strategies to improve safety and tolerability of a cornerstone therapy, though it is less directly informative about core…